| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.02 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.02 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.39 | 0.02 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.03 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.13 | 0.03 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.03 |